Changes of Serum SE-CAD, CA19-9 and VEGF Levels in Patientswith Primary Hepatic Cancer Before and After Intervention Therapy

Changes of Serum SE-CAD, CA19-9 and VEGF Levels in Patientswith Primary Hepatic Cancer Before and After Intervention Therapy

YANG Hua-xi

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

Labeled Immunoassays and Clinical Medicine ›› 2007, Vol. 14 ›› Issue (1) : 4-6.

Orignal Article

Changes of Serum SE-CAD, CA19-9 and VEGF Levels in Patientswith Primary Hepatic Cancer Before and After Intervention Therapy

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2007, 14(1): 4-6

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉